These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28435224)

  • 1. Investigation of triamterene as an inhibitor of the TGR5 receptor: identification in cells and animals.
    Li Y; Cheng KC; Niu CS; Lo SH; Cheng JT; Niu HS
    Drug Des Devel Ther; 2017; 11():1127-1134. PubMed ID: 28435224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursolic acid activates the TGR5 receptor to enhance GLP-1 secretion in type 1-like diabetic rats.
    Lo SH; Li Y; Cheng KC; Niu CS; Cheng JT; Niu HS
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Nov; 390(11):1097-1104. PubMed ID: 28756460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dietary Furocoumarin Imperatorin Increases Plasma GLP-1 Levels in Type 1-Like Diabetic Rats.
    Wang LY; Cheng KC; Li Y; Niu CS; Cheng JT; Niu HS
    Nutrients; 2017 Oct; 9(11):. PubMed ID: 29084156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of betulinic acid as an agonist of TGR5 receptor using a new in vitro assay.
    Lo SH; Cheng KC; Li YX; Chang CH; Cheng JT; Lee KS
    Drug Des Devel Ther; 2016; 10():2669-76. PubMed ID: 27578964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycyrrhizic acid increases glucagon like peptide-1 secretion via TGR5 activation in type 1-like diabetic rats.
    Wang LY; Cheng KC; Li Y; Niu CS; Cheng JT; Niu HS
    Biomed Pharmacother; 2017 Nov; 95():599-604. PubMed ID: 28881290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spergularia marina induces glucagon-like peptide-1 secretion in NCI-H716 cells through bile acid receptor activation.
    Kim K; Lee YM; Rhyu MR; Kim HY
    J Med Food; 2014 Nov; 17(11):1197-203. PubMed ID: 25260089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ginsenoside metabolite compound K stimulates glucagon-like peptide-1 secretion in NCI-H716 cells via bile acid receptor activation.
    Kim K; Park M; Lee YM; Rhyu MR; Kim HY
    Arch Pharm Res; 2014; 37(9):1193-200. PubMed ID: 24590628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly lipophilic 3-epi-betulinic acid derivatives as potent and selective TGR5 agonists with improved cellular efficacy.
    Wang XY; Zhang SY; Li J; Liu HN; Xie X; Nan FJ
    Acta Pharmacol Sin; 2014 Nov; 35(11):1463-72. PubMed ID: 25283506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Andrographolide as an Agonist of Bile Acid TGR5 Receptor in a Cell Line to Demonstrate the Reduction in Hyperglycemia in Type-1 Diabetic Rats.
    Li Y; Cheng KC; Liu IM; Cheng JT
    Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet α Cells to Promote Glucose Homeostasis.
    Kumar DP; Asgharpour A; Mirshahi F; Park SH; Liu S; Imai Y; Nadler JL; Grider JR; Murthy KS; Sanyal AJ
    J Biol Chem; 2016 Mar; 291(13):6626-40. PubMed ID: 26757816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of a TGR5 agonist and a dipeptidyl peptidase IV inhibitor on dextran sulfate sodium-induced colitis in mice.
    Sakanaka T; Inoue T; Yorifuji N; Iguchi M; Fujiwara K; Narabayashi K; Kakimoto K; Nouda S; Okada T; Kuramoto T; Ishida K; Abe Y; Takeuchi T; Umegaki E; Akiba Y; Kaunitz JD; Higuchi K
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1(Suppl 1):60-5. PubMed ID: 25827806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGR5 agonist ameliorates insulin resistance in the skeletal muscles and improves glucose homeostasis in diabetic mice.
    Huang S; Ma S; Ning M; Yang W; Ye Y; Zhang L; Shen J; Leng Y
    Metabolism; 2019 Oct; 99():45-56. PubMed ID: 31295453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl peptidase IV inhibition potentiates amino acid- and bile acid-induced bicarbonate secretion in rat duodenum.
    Inoue T; Wang JH; Higashiyama M; Rudenkyy S; Higuchi K; Guth PH; Engel E; Kaunitz JD; Akiba Y
    Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(7):G810-6. PubMed ID: 22821947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DS-8500a, an Orally Available G Protein-Coupled Receptor 119 Agonist, Upregulates Glucagon-Like Peptide-1 and Enhances Glucose-Dependent Insulin Secretion and Improves Glucose Homeostasis in Type 2 Diabetic Rats.
    Matsumoto K; Yoshitomi T; Ishimoto Y; Tanaka N; Takahashi K; Watanabe A; Chiba K
    J Pharmacol Exp Ther; 2018 Dec; 367(3):509-517. PubMed ID: 30217957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-2 promotes gallbladder refilling via a TGR5-independent, GLP-2R-dependent pathway.
    Yusta B; Matthews D; Flock GB; Ussher JR; Lavoie B; Mawe GM; Drucker DJ
    Mol Metab; 2017 Jun; 6(6):503-511. PubMed ID: 28580281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Betulinic Acid Derivatives as Potent TGR5 Agonists with Antidiabetic Effects via Humanized TGR5
    Yun Y; Zhang C; Guo S; Liang X; Lan Y; Wang M; Zhuo N; Yin J; Liu H; Gu M; Li J; Xie X; Nan F
    J Med Chem; 2021 Aug; 64(16):12181-12199. PubMed ID: 34406006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
    Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
    Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Farnesoid X receptor induces Takeda G-protein receptor 5 cross-talk to regulate bile acid synthesis and hepatic metabolism.
    Pathak P; Liu H; Boehme S; Xie C; Krausz KW; Gonzalez F; Chiang JYL
    J Biol Chem; 2017 Jun; 292(26):11055-11069. PubMed ID: 28478385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice.
    Li Z; Huang J; Wang F; Li W; Wu X; Zhao C; Zhao J; Wei H; Wu Z; Qian M; Sun P; He L; Jin Y; Tang J; Qiu W; Siwko S; Liu M; Luo J; Xiao J
    J Bone Miner Res; 2019 Apr; 34(4):765-776. PubMed ID: 30536462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OL3, a novel low-absorbed TGR5 agonist with reduced side effects, lowered blood glucose via dual actions on TGR5 activation and DPP-4 inhibition.
    Ma SY; Ning MM; Zou QA; Feng Y; Ye YL; Shen JH; Leng Y
    Acta Pharmacol Sin; 2016 Sep; 37(10):1359-1369. PubMed ID: 27264313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.